
Nasal Spray Available Without Prescription Cuts COVID-19 Infection Risk by 67%, Study Shows
It was reported that a recent clinical trial revealed that an over-the-counter nasal spray containing azelastine has the potential to reduce the risk of catching Covid-19 by approximately 67%. Azelastine, an antihistamine that is widely taken to treat allergies, showed a high level of protection in this study. Recently, CDC uncertainty disrupted COVID-19 vaccine access